Return on Assets (ROA)
since 2005
Calculation
Edwards Lifesciences Corp., ROA, long-term trends, calculation
| ROA | = | 100 | × | Net income1 | ÷ | Total assets1 | |
|---|---|---|---|---|---|---|---|
| Dec 31, 2021 | 17.68% | = | 100 | × | 1,503,100) | ÷ | 8,502,600) |
| Dec 31, 2020 | 11.38% | = | 100 | × | 823,400) | ÷ | 7,237,100) |
| Dec 31, 2019 | 16.14% | = | 100 | × | 1,046,900) | ÷ | 6,488,100) |
| Dec 31, 2018 | 13.57% | = | 100 | × | 722,200) | ÷ | 5,323,700) |
| Dec 31, 2017 | 10.25% | = | 100 | × | 583,600) | ÷ | 5,695,800) |
| Dec 31, 2016 | 12.63% | = | 100 | × | 569,500) | ÷ | 4,510,000) |
| Dec 31, 2015 | 12.19% | = | 100 | × | 494,900) | ÷ | 4,059,300) |
| Dec 31, 2014 | 23.01% | = | 100 | × | 811,100) | ÷ | 3,524,300) |
| Dec 31, 2013 | 14.38% | = | 100 | × | 391,700) | ÷ | 2,724,700) |
| Dec 31, 2012 | 13.20% | = | 100 | × | 293,200) | ÷ | 2,221,500) |
| Dec 31, 2011 | 11.95% | = | 100 | × | 236,700) | ÷ | 1,980,500) |
| Dec 31, 2010 | 12.34% | = | 100 | × | 218,000) | ÷ | 1,767,200) |
| Dec 31, 2009 | 14.18% | = | 100 | × | 229,100) | ÷ | 1,615,500) |
| Dec 31, 2008 | 9.21% | = | 100 | × | 128,900) | ÷ | 1,400,200) |
| Dec 31, 2007 | 8.40% | = | 100 | × | 113,000) | ÷ | 1,345,100) |
| Dec 31, 2006 | 10.47% | = | 100 | × | 130,500) | ÷ | 1,246,800) |
| Dec 31, 2005 | 6.45% | = | 100 | × | 79,300) | ÷ | 1,229,100) |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$ in thousands
The financial data reveals several notable trends and insights over the analyzed period. Net income exhibits a general upward trajectory, indicating increasing profitability with fluctuations in certain years. Starting from 79,300 thousand US dollars, net income rose notably, reaching a peak of 1,046,900 thousand US dollars in 2019. Some periods reflected setbacks, such as declines in 2015 and 2020, but the overall trend remains strongly positive.
Total assets followed a consistent growth pattern, reflecting significant expansion in the company's asset base. From 1,229,100 thousand US dollars at the beginning of the period, total assets increased steadily to 8,502,600 thousand US dollars by the end. This steady increase suggests ongoing investments and growth activities, with particularly strong asset growth after 2012.
The return on assets (ROA) ratio provides additional insight into asset efficiency and profitability. ROA peaked at 23.01% in 2014, indicating extremely efficient use of assets that year. However, this was followed by a decline in subsequent years, though ROA remained relatively strong and hovered around double digits. The ratio reached a low point in 2015 at 12.19% but saw recovery afterward, attaining 17.68% in 2021. These fluctuations in ROA could suggest varying operational efficiency or profit margin impacts despite growing asset bases.
- Net Income
- Shows a general upward trend with peaks and troughs; significant increases particularly from 2013 to 2019, peaking above 1 billion US dollars, followed by a decrease in 2020 and a recovery in 2021.
- Total Assets
- Displays consistent and robust growth throughout the period, more than sextupling over 16 years, indicative of asset accumulation and expansion strategies.
- Return on Assets (ROA)
- Varies over time with a high point in 2014 (23.01%), suggesting exceptional asset utilization efficiency that year, followed by declines and moderate recovery, reflecting changing profitability relative to asset size.
Overall, the company demonstrates financial growth with increasing net income and asset base, though efficiency as measured by ROA displays some variability, underscoring the importance of managing profitability alongside asset growth.
Comparison to Competitors
Edwards Lifesciences Corp., ROA, long-term trends, comparison to competitors
| Edwards Lifesciences Corp. | Abbott Laboratories | CVS Health Corp. | Elevance Health Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|---|---|
| Dec 31, 2021 | 17.68% | 9.40% | 3.39% | 6.26% | 12.58% | 3.87% | 8.15% |
| Dec 31, 2020 | 11.38% | 6.20% | 3.11% | 5.28% | 9.50% | 5.28% | 7.81% |
| Dec 31, 2019 | 16.14% | 5.43% | 2.98% | 6.21% | 14.17% | 5.16% | 7.96% |
| Dec 31, 2018 | 13.57% | 3.53% | -0.30% | 5.24% | 14.37% | 3.40% | 7.87% |
| Dec 31, 2017 | 10.25% | 0.63% | 6.96% | 5.45% | 11.46% | 4.04% | 7.59% |
| Dec 31, 2016 | 12.63% | 2.66% | 5.63% | 3.79% | 11.34% | 3.55% | 5.71% |
| Dec 31, 2015 | 12.19% | 10.72% | 5.59% | 4.15% | 12.00% | 2.51% | 5.22% |
| Dec 31, 2014 | 23.01% | 5.53% | 6.25% | 4.14% | 10.58% | 8.08% | 6.50% |
| Dec 31, 2013 | 14.38% | 6.00% | 6.42% | 4.18% | 16.99% | 9.95% | 6.87% |
| Dec 31, 2012 | 13.20% | 8.87% | 5.88% | 4.50% | 16.18% | 10.93% | 6.83% |
| Dec 31, 2011 | 11.95% | 7.84% | 5.36% | 5.09% | 16.16% | 10.18% | 7.57% |
| Dec 31, 2010 | 12.34% | 7.78% | 5.51% | 5.75% | 15.97% | 11.03% | 7.35% |
| Dec 31, 2009 | 14.18% | 10.96% | 6.00% | 9.10% | 12.85% | 9.17% | 6.47% |
| Dec 31, 2008 | 9.21% | 11.51% | 5.27% | 5.15% | 13.86% | 10.05% | 5.33% |
| Dec 31, 2007 | 8.40% | 9.08% | 4.82% | 6.43% | 13.90% | 14.36% | 9.14% |
| Dec 31, 2006 | 10.47% | 4.75% | 6.65% | 5.98% | 10.72% | 12.95% | 8.61% |
| Dec 31, 2005 | 6.45% | 11.57% | 8.01% | 4.79% | 18.77% | 10.86% | 7.98% |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Health Care Equipment & Services)
Edwards Lifesciences Corp., ROA, long-term trends, comparison to sector (health care equipment & services)
| Edwards Lifesciences Corp. | Health Care Equipment & Services | |
|---|---|---|
| Dec 31, 2021 | 17.68% | 6.03% |
| Dec 31, 2020 | 11.38% | 5.44% |
| Dec 31, 2019 | 16.14% | 5.46% |
| Dec 31, 2018 | 13.57% | 3.71% |
| Dec 31, 2017 | 10.25% | 5.38% |
| Dec 31, 2016 | 12.63% | 4.64% |
| Dec 31, 2015 | 12.19% | 5.08% |
| Dec 31, 2014 | 23.01% | 6.08% |
| Dec 31, 2013 | 14.38% | 6.59% |
| Dec 31, 2012 | 13.20% | 7.19% |
| Dec 31, 2011 | 11.95% | 7.03% |
| Dec 31, 2010 | 12.34% | 7.18% |
| Dec 31, 2009 | 14.18% | 8.14% |
| Dec 31, 2008 | 9.21% | 6.92% |
| Dec 31, 2007 | 8.40% | 7.89% |
| Dec 31, 2006 | 10.47% | 7.31% |
| Dec 31, 2005 | 6.45% | 7.94% |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Edwards Lifesciences Corp., ROA, long-term trends, comparison to industry (health care)
| Edwards Lifesciences Corp. | Health Care | |
|---|---|---|
| Dec 31, 2021 | 17.68% | 8.70% |
| Dec 31, 2020 | 11.38% | 5.45% |
| Dec 31, 2019 | 16.14% | 7.57% |
| Dec 31, 2018 | 13.57% | 6.72% |
| Dec 31, 2017 | 10.25% | 5.31% |
| Dec 31, 2016 | 12.63% | 7.18% |
| Dec 31, 2015 | 12.19% | 7.54% |
| Dec 31, 2014 | 23.01% | 8.41% |
| Dec 31, 2013 | 14.38% | 8.58% |
| Dec 31, 2012 | 13.20% | 7.94% |
| Dec 31, 2011 | 11.95% | 7.22% |
| Dec 31, 2010 | 12.34% | 7.11% |
| Dec 31, 2009 | 14.18% | 9.45% |
| Dec 31, 2008 | 9.21% | 9.08% |
| Dec 31, 2007 | 8.40% | 8.51% |
| Dec 31, 2006 | 10.47% | 10.37% |
| Dec 31, 2005 | 6.45% | 9.62% |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).